Markers in Cancer: A joint meeting by ASCO, EORTC and NCI
November 7, 2013 - November 9, 2013
Venue: Brussels, Belgium
Next generation sequencing and high throughput screening technologies are revolutionizing our current molecular understanding of cancer. Molecular tumor profiles can now be established at affordable cost within a timeframe compatible with clinical practice. It is anticipated, that biomarker-based patient selection will soon move to the forefront of effective cancer treatment.
Markers in Cancer, a joint meeting by ASCO, EORTC & NCI, will focus on the relevance and the feasibility of implementing emerging technologies into clinical practice.
A tutorial on biomarker development dealing with issues related to next generation trial design (5-7 November 2013) will precede the Main Meeting and is open to early career oncologists.
Next events
EORTC Pathobiology Group Spring Meeting
April 24
Virtual Event
EORTC Head and Neck Cancer Group Spring Meeting
April 26 - April 27
Hamburg, DE
ESTRO 2024
May 3 - May 7
Glasgow
EORTC Lung Cancer Group Spring Meeting
May 16 - May 18
Malaga, Spain
EORTC Gynecological Cancer Group Spring Meeting
May 16 - May 17
Barcelona, Spain